Shrinking upper and lower eyelid skin with a novel radiofrequency tip.

Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Abstract Text:

Jean Carruthers,Alastair Carruthers,Jean Carruthers,Alastair Carruthers,

BACKGROUND: Many subjects wish to have tightening of eyelid skin but are reluctant to undergo aesthetic blepharoplasty surgery. We wanted to perform a small pilot study to test the efficacy and safety of a 0.25-cm(2) monopolar radiofrequency tip in a prospective noncomparative study as a novel nonsurgical method to safely tighten upper and lower eyelid skin in subjects of differing ethnicity and sex. METHODS: Twenty adult subjects were enrolled in this prospective pilot study. All received symmetrical monopolar radiofrequency treatments in multiple passes to the pretarsal, preseptal, and lateral orbital skin. All subjects wore a protective plastic haptic contact lens to protect their vision during the radiofrequency treatment. (Haptic contact lenses fit over the entire anterior surface of the globe from superior to inferior and medial to lateral fornix. The purpose of using such a large contact lens was to protect the globe itself from radiofrequency energy.) Standardized color digital photography with eyes both open and closed was taken on each visit. Treatment efficacy was evaluated by both the expert observer and the subject at each visit. RESULTS At 6-month follow-up, according to the expert observer, 26 upper lids (87%) showed 25% or more tightening. Twenty lower lids (67%) showed 25% or more tightening. Two subjects (3.33%) had 51% to 75% upper lid tightening at 6 months. There were no adverse events beyond one subject with minimal corneal epithelial punctate defects on the treatment day. These resolved over several hours. CONCLUSIONS: The use of this new tip was shown to be safe. Effectiveness at shrinking eyelid skin was at best mild to moderate.

Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Publishing Authors By Initials

J Carruthers,A Carruthers,J Carruthers,A Carruthers,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Dermatologic surgery : official publication for Am

VOLUME: 33

Page Numbers: 802-9

Journal Abbreviation:

ISSN: 1524-4725

DAY: 29

MONTH: Jul

YEAR: 2007

Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9504371

Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Shrinking upper and lower eyelid skin with a novel radiofrequency tip.

AFFILIATION: Department of Ophthalmology, University of British Columbia, Vancouver, British Columbia, Canada. jean@carruthers.net

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Dermatol Surg

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Shrinking upper and lower eyelid skin with a novel radiofrequency tip Related Publications

• 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
• A cleavable propeptide influences Toxoplasma infection by facilitating the trafficking and secretion of the TgMIC2-M2AP invasion complex.
• A transient forward-targeting element for microneme-regulated secretion in Toxoplasma gondii.
• ATP-dependent sugar transport complexity in human erythrocytes.
• Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
• Broadening discussions of "safe" in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice.
• Caveat emptor (buyer beware).
• Discussion: the history of injectable silicone fluids for soft-tissue augmentation.
• Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
• Elderly patients with hypertension should retain 'special' status.
• Endocrine and superovulatory responses in heifers pretreated with FSH or bovine follicular fluid.
• Host cell manipulation by the human pathogen Toxoplasma gondii.
• Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
• Laboratory testing of spermicidal preparation.
• Lead identification of acetylcholinesterase inhibitors-histamine H(3) receptor antagonists from molecular modeling.
• MARveling at parasite invasion.
• Mad cows, prions, and wrinkles.
• Malakoplakia: report of a case.
• Patient-reported outcomes with botulinum neurotoxin type A.
• Recent medicinal chemistry of the histamine H3 receptor.
• Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.
• Shrinking upper and lower eyelid skin with a novel radiofrequency tip.
• Some points in the diagnosis of labyrinthine vertigo and a survey of methods of treatment, medical and surgical.
• Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.
• The J-curve--it is clinically relevant?
• The diagnosis of late life hypogonadism.
• The evolution of botulinum neurotoxin type A for cosmetic applications.
• The organization of a community: community-based prevention of injecting drug use-related health problems.
• The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.
• [Not Available.]